Article

Managing Lung Cancer Patients Through the COVID-19 Pandemic: What to Know

Author(s):

Join top leaders in the lung cancer field as they share their insights on COVID-19 and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system on Thursday, May 14, 2020 at 8 PM EST.

Date/Time: Thursday, May 14, 2020 at 8 PM EST

Join oncologists nationwide who have learned from the top leaders in the lung cancer field as they share their insights on COVID-19 and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system.

Led by Nathan A. Pennell, MD, PhD; Stephen Liu, MD; H. Jack West, MD; Charu Aggarwal, MD, MPH, this webinar will cover all of the key information on treating your patients with lung cancer, who could be at risk for developing COVID-19.

Click here to register today!

Speakers:
Nathan A. Pennell, MD, PhD, Associate Professor; Director, Lung Cancer Medical Oncology Program,Cleveland Clinic, Cleveland, OH

Stephen Liu, MD, Associate Professor of Medicine; Director, Thoracic Oncology, Georgetown University, Washington, DC

Charu Aggarwal, MD, MPH, Leslye M. Heisler Assistant Professor of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

H. Jack West, MD, Associate Clinical Professor in Medical Oncology; Executive Director, Employer Services, City of Hope Comprehensive
Cancer Center, Irwindale, CA

Anna F. Farago, MD, PhD, Guest Speaker; Medical Oncologist, The Center for Thoracic Cancers at Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School Boston, Massachusetts

Related Videos
Sandip P. Patel, MD
Alec Watson, MD
Balazs Halmos, MD
Balazs Halmos, MD
Suresh Senan, MRCP, FRCR, PhD, full professor, treatment and quality of life, full professor, cancer biology and immunology, full professor, radiation oncology, professor, clinical experimental radiotherapy, Amsterdam University Medical Centers
Alison Schram, MD
Mary B. Beasley, MD, discusses molecular testing challenges in non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the multidisciplinary management of NRG1 fusion–positive non–small cell lung cancer and pancreatic cancer.
Mary B. Beasley, MD, discusses the role of pathologists in molecular testing in non–small cell lung cancer and pancreatic cancer.